about
Interferon-alpha, immune activation and immune dysfunction in treated HIV infectionTuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsRelationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis.B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection.Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfectionAntiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Impaired CTLA-4 responses in COPD are associated with systemic inflammationBiomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesisCryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsGenetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 alleleElevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?Persistent immune activation in chronic HIV infection: do any interventions work?Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or deathResumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trialPlasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial.STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and functionViremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection.Immune restoration disease: a consequence of dysregulated immune responses after HAART.Immune restoration disease after antiretroviral therapy.Functional STAT3 deficiency compromises the generation of human T follicular helper cells.Factors Associated With Plasma IL-6 Levels During HIV Infection.Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation.Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration diseaseBiomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis virusesDisorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy.The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized.HIV and co-infections.Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets.Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficienciesImmunosenescent CD57+CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART.Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells.HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal.Immune restoration diseases reflect diverse immunopathological mechanisms.Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings.
P50
Q26861003-20FBAECB-A926-4D62-B74E-AC03835A04E7Q28749315-7D616FB4-BF8B-4346-A818-5CAF7C641562Q33609454-982C60AC-2C04-4F5E-B35D-330E47C4431DQ33615168-E98DF430-8D1E-484F-B4A5-38B40261417AQ33626626-3A0C2A82-703E-4F9E-BE54-F8DF6757D183Q33831703-F91B97E0-A4A2-4AE3-8756-371002BF6B93Q33867299-20DFD5B1-5B88-436B-9177-EAAB96D218F2Q34455601-4D421E23-BA23-42F4-B83A-535FF7626482Q34505245-081EAD4F-443D-49A1-B97B-0DA89B5A61C3Q34516548-B199445B-4771-47D8-8E9C-BF3E8F471CDDQ34545588-24FC24BC-5250-41CE-A494-C9006234ED36Q34784783-C8475F27-9E4C-4A00-9BDC-9799EDA68BD1Q34851102-ACF8052F-6566-4553-9CC6-B928EE0A2992Q34988273-C0AA1248-27FA-432B-A9C8-7F6FDEF793ADQ35006056-36EEE584-2DF3-42AF-8F66-3CB971E66654Q35629714-805E67A5-055C-41C0-8AAA-8671FADE64A0Q35671239-D8E25A98-B84B-4F76-ACE1-1AE55B2C57F6Q35823060-4D51EAEF-E5DE-47C5-BD47-5CCE09629770Q35826668-8A261A3A-2B70-478B-93CD-AB68EA52F77CQ35848180-7373733F-C3C9-4FCA-A287-673165FABCA2Q35849105-7673FB43-44A8-4493-97C3-C29AA240E345Q35970620-D8DD0FBF-988A-41DB-9A73-3BBA61C0220FQ36139186-A6BA03DA-B9D4-4DF7-B340-05792789D6BDQ36187510-1D8BF06B-F189-437A-BB61-04C4E8AD149DQ36408161-117B072C-C264-41B3-9470-B1E38AB706A5Q36667604-14A9514B-3B70-43DE-905E-BD5431D776D1Q36723335-CE274594-7A3F-4052-A04A-333BCDE01459Q36752233-4375C198-4990-4BD2-AA26-5E31736FA67EQ36905011-EAD017D4-FD20-4AAE-A8DD-422E03CE45A8Q36970184-C0F492A9-0A8D-479F-BD7B-386010B461B8Q37109543-A25C4EDA-2601-4DE7-881E-0091F878B6DDQ37178987-0A217550-C32A-4C06-A418-C605BC91B0FEQ37202661-E922AB01-E2B7-4B55-9FE1-543A2E6D4883Q37247472-BC6888CB-FD4D-4325-AC1E-93E8AE348350Q37296295-00F3A27C-0755-4797-9D79-FFC1C2A14C52Q37304847-017B5FCD-CE48-44FE-BF8C-9C02870D7BAEQ37322185-E49C5FCB-34C3-404E-A03D-B2C596EE373DQ37331818-AFDFB9ED-9B1D-4912-9A85-8B8D5CAF1967Q37409995-2303F695-C3BB-4E9C-94AB-F8286BDA1D62Q37447342-565B8167-E95B-4669-903B-49C1DE163D03
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martyn A. French
@ast
Martyn A. French
@en
Martyn A. French
@es
Martyn A. French
@nl
Martyn A. French
@sl
type
label
Martyn A. French
@ast
Martyn A. French
@en
Martyn A. French
@es
Martyn A. French
@nl
Martyn A. French
@sl
prefLabel
Martyn A. French
@ast
Martyn A. French
@en
Martyn A. French
@es
Martyn A. French
@nl
Martyn A. French
@sl
P1153
P106
P1153
34667860200
56927689300
7202594947
P21
P31
P496
0000-0002-4644-1982